fda glp-1 warning news november 2025 New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our March 31, 2025: Senator asks

She tried an antidepressant that didnt help

We require you to have a face to face consultation to allow us to prepare a prescription for you

Consistency : Take supplements at the same times each day for optimal effect

Patients are voting with their wallets and respiratory therapists and physicians are voting with their recommendations and their prescriptions. Where some medtech leaders might see GLP-1 drugs as a big threat to their territory, Farrell sees it as an opportunity to funnel more people toward CPAP treatment by boosting awareness of chronic diseases like sleep apnea, and driving more people who suffer from these diseases into treatment pathways they may not have been previously open to or aware of, such as CPAP machines